City Sanofi Financial News

07.01 / 21:29
markets Career CEO President Sarepta information reports Calliditas names Maria Törnsén President North America
STOCKHOLM — Calliditas Therapeutics AB (NASDAQ:CALT) (Nasdaq Stockholm: CALTX), a biopharmaceutical company specializing in rare diseases, today announced the appointment of Maria Törnsén as President of its North American operations. Törnsén, who brings over two decades of experience in the biopharma sector, will oversee all U.S. operations and report directly to the CEO, Renée Aguiar-Lucander.
01.01 / 07:50
Provident Manufacturing performer reports 2024 Pharma Outlook 2024: How are Cipla, Sun Pharma, Dr Reddy's and others likely to perform this year?
Cipla, Torrent Pharma, Eris Lifesciences, and JB Chemicals, among others) have increased their chronic presence, focused on new product launches, and entered into new therapies. API (Active Pharmaceutical Ingredient) companies are undergoing capex, which will aid in further top-line growth; a healthy product mix and softening input costs are likely to sustain higher operating margins of ~20-30% in CY24.
27.10 / 15:33
Target Reuters Progressive CEO Hudson innovations reports market value Sanofi stock plunges 15.5% after changes in 2025 profit target, loses $21 billion in market value
Reuters reported. This comes after Sanofi decided to reconsider the 32% profit target for 2025 to focus on "long-term profitability". The drugmaker has decided to increase the spending on immunology and inflammation drug development.
27.10 / 12:33
Manufacturing CEO JPMorgan Mobile Chevron reports fall Amazon, Intel, Exxon Mobil rise premarket; Ford, Chevron fall
Investing.com — U.S. futures rose Friday, boosted by strong numbers from a couple of tech giants ahead of the release of key inflation data.
25.10 / 04:39
Immunic vaccine Virus reports recommendations prevention symptoms A new RSV shot for infants is in short supply
A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease
10.10 / 11:09
Lowe's Target Extreme Manufacturing Sanofi spinoff EuroAPI’s shares plunge on sales surprise
EuroAPI, the pharma-ingredients firm spun off by Sanofi last year, plunged as much as 61% after cutting its guidance and saying it would embark on a strategic review.
09.10 / 13:05
UPS Reuters Mobile Shell reports Bristol-Myers Squibb shells out billions for Mirati: 5 big deal reports
Investing.com — Here is your Pro Recap of 5 head-turning deal dispatches you may have missed last week: deals at Bristol Myers Squibb/Mirati Therapeutics, Eli Lilly/Point Biopharma, Suncor Energy/TotalEnergies, deal talks at Exxon Mobil/Pioneer Natural Resources, and potential sale of EngageSmart.
17.08 / 19:39
UPS Progressive Manufacturing Sarepta pricing Government in talks with companies over pricing of rare diseases drugs
drugs used for treatment of rare diseases with pharmaceutical companies including Sanofi, Sarepta and Roche to bring relief to patients who are unable get treatment due to exorbitant prices of drugs. «Discussions relating to pricing and supplies of medicines with various pharma companies are underway,» the government has informed the Delhi High Court that has been hearing a batch of petitions filed by rare disease patients and their caretakers.
11.08 / 02:11
Enterprise HAL Hero Stocks in news: LIC, Hero MotoCorp, Nykaa, Adani Wilmar, Biocon
LICLife Insurance Corp's (LIC) standalone net profit rose multifold to Rs 9,544 crore for the quarter ended June.HeroHero MotoCorp reported a 32% growth in net profit for the quarter ended June to Rs 825 crore. Revenue from operations grew 4.5% YoY to Rs 8,767 crore.BioconBiocon reported net profit of Rs 101 crore in the June quarter.
04.08 / 20:27
COST Provident Fighting Pfizer Immunic cover rsv approved Babies should get recently approved drug for RSV, CDC says
U.S. health officials are recommending that babies get a recently approved drug to protect them against a respiratory virus
25.07 / 21:15
CEO Hennessy beautiful LVMH 2024 Luxury group LVMH joins top-tier French sponsors of the 2024 Paris Olympics and Paralympics
The world’s biggest luxury group, LVMH Moët Hennessy Louis Vuitton, has announced a sponsorship deal with the 2024 Paris Olympics and Paralympics
24.07 / 11:19
UPS Microsoft NASDAQ Tesla show market value week Companies with $27T market value report earnings this week
It’s shaping up to be a pivotal week for global stocks, as companies with a combined $27 trillion market value gear up to report quarterly earnings. As Netflix Inc. and Tesla Inc. showed last week, the pressure is on — to deliver or face a sharp selloff.
21.07 / 13:25
UPS Pfizer rsv EU regulator backs Pfizer's RSV vaccine for infants, older adults
(Reuters) -The European Union's health regulator on Friday backed authorization of Pfizer (NYSE:PFE)'s vaccine for respiratory syncytial virus (RSV) for use in babies and older adults.
17.06 / 15:23
Target Strategy Bayer Santander Dalio is right to short Europe, strategist says: 'The pain will go on for quite a while'
Billionaire investor Ray Dalio is right to have bet against European stocks, and global markets still have a rough road ahead, according to Beat Wittmann, partner at Zurich-based Porta Advisors.

breaking news about city Sanofi

What is the current situation in city Sanofi?

In city Sanofi, the spotlight is on major events that affect the region’s daily life.

Where can I find reliable news about city Sanofi?

We publish reliable reports about the situation in city Sanofi, based on information from regional journalists.

What shapes the media agenda in city Sanofi?

The news landscape of city Sanofi is shaped by major cultural and social events, reflecting its local way of life.